Abbott India Limited vs CESC Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and CESC Limited (Electric utilities) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, CESC Limited leads on Revenue (approx.) and Net profit (approx.).
CESC Limited leads on Revenue (approx.) and Net profit (approx.).
Choose Abbott India Limited if you want exposure to higher-margin branded pharmaceuticals, supported by recognized therapeutic brands, strong parentage, and an established doctor and pharmacy network. Choose CESC Limited if you prefer a regulated utility profile with relatively stable demand, an established urban franchise, and integrated generation and distribution capabilities. The right choice depends on whether the buyer prioritizes branded pharma growth characteristics or regulated utility stability, as both have meaningful concentration and regulatory risks.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | CESC Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 14,000-16,000 crore, unverified range | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately INR 1,300-1,600 crore, unverified range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
CESC Limited
Electric utilities · India
CESC Limited is an Indian power utility focused on electricity generation, transmission, and distribution, with its core regulated utility operations centered in Kolkata and nearby areas. It is part of the RP-Sanjiv Goenka Group and also operates or invests in power distribution and generation businesses through subsidiaries.
Verified financials
No source-verified financials available.
Strengths
- Established utility franchise in a dense urban market
- Regulated revenue base with relatively stable demand
- Integrated generation and distribution capabilities
- Backing of the RP-Sanjiv Goenka Group
Weaknesses
- Geographic concentration in core regulated operations
- Exposure to regulatory tariff decisions
- Legacy thermal power dependence
- Capital-intensive infrastructure requirements
Opportunities
- Expansion in renewable energy and cleaner generation
- Distribution franchise opportunities in other regions
- Grid modernization and smart metering
- Rising urban electricity demand
Threats
- Regulatory pressure on tariffs and returns
- Fuel cost volatility for thermal generation
- Competition from distributed solar and open access power
- Operational risks from aging network infrastructure
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs CESC Limited: which company leads overall?
CESC Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Electric Commercial Vehicles Market — Intelligence Report
India Electric Vehicle Charging Infrastructure Market — Intelligence Report
India Protein Industry Outlook — Intelligence Report
India Pharmaceutical Sector — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs CESC Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is a pharmaceutical company in India and a listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across areas including gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
- CESC Limited is an Indian electric utility focused on electricity generation, transmission, and distribution, with core regulated utility operations centered in Kolkata and nearby areas.
- Notable: The two companies operate in distinct regulated sectors in India, with Abbott India focused on pharmaceuticals and CESC focused on electric utilities.